Information Library

Results for: Brochures - Clinical Services - Phase I/IIa

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Accelerating Success in Oncology

    March 9, 2012
    New Demands to Demonstrate Value Require New Strategy Proof of efficacy is no longer enough to ensure success in oncology. As the cost and complexity

  • Early Clinical Development Solutions

    March 8, 2012
    As the leader in clinical development services, with experience in more than 1,000 first-in-human and exploratory medical studies, Quintiles understands the intricacies of Phase 1/11a trials and decision making.

  • Cardiac Safety Solutions

    January 17, 2012
    Learn how you can proactively assess and manage cardiac safety issues for your entire product development process with the help of our cardiovascular experts and core ECG laboratory providing validated methodology, sophisticated technology and reliable data.

  • A Focus on CNS

    July 1, 2011
    Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process.

  • Genomics Fact Sheet

    June 17, 2011
    Approximately 20% of today’s U.S. Clinical Trials use genomic technology. Find out about Quintiles’ offerings in this area.

  • Population PK/PD - Modeling and Simulation Optimization Tools

    February 11, 2011
    Population pharmacokinetic/ pharmacodynamic (PK/PD) modeling and simulation, available from Quintiles, is now endorsed by the FDA as often being instrumental in drug approval and labeling.

  • The New Health Clinical Brochure

    August 31, 2010
    Japanese version available for download.

  • Targeting Oncology

    June 2, 2010
    Learn more about Quintiles leadership in oncology product development and commercialization.

  • Emerging Biopharma Service Fact Sheet

    May 4, 2010
    Recognizing that the needs of emerging companies are unique, Quintiles has created a specialized team dedicated exclusively to small and mid-sized biopharma companies.

  • TQT Studies: Integrated Cardiac Expertise for Smarter Decisions, Sooner

    April 13, 2010
    At Quintiles, we offer you a complete solution for your TQT needs including our Phase I, Clinical Pharmacology and ECG Core Labs.

Page 1 of 2 (13 results)

Subscribe to Email Based on Your Interests

Set preferences